LATITUDE Pharmaceuticals Inc.
9675 Businesspark Avenue
San Diego, CA 92131
T: (858) 546-0624
LATITUDE: Your Formulation Specialist
LATITUDE Pharmaceuticals is a leading-edge CDMO that provides innovative drug formulation development services and GMP manufacturing for early-phase clinical trials to the human and animal health industries. Founded in 2003, we have completed more than 1,000 client projects and have established a reputation for successfully formulating highly insoluble compounds – the most significant cause of drug development failure.
LATITUDE’s formulation scientists overcome the challenges of difficult compounds, and are the foundation of LATITUDE’s reputation for creative approaches, reliability, transparency, rapid turnaround, and client satisfaction. LATITUDE’s extensive experience and technical strengths in a wide range of dosage forms are applied to help our clients successfully address even the most difficult formulation challenges including solubility, instability, bioavailability and in vivo adverse reactions. LATITUDE scientists have particular expertise in the formulation of complex injectables including nanoemulsions, liposomes, microspheres and nanoparticles.
LATITUDE has developed the following specialized drug delivery platforms:
LATITUDE Pharmaceuticals provides GLP- and GMP-compliant manufacturing and analytical testing services – we specialize in rapid customer response and delivery of Phase 1 and Phase 2 clinical trial materials. With a Quality Assurance System managed by experienced and dedicated staff, LATITUDE can GLP or GMP manufacture a variety of dosage forms including sterile injectable or ophthalmic drugs, as well as non-sterile oral or topical formulations, to support GLP toxicology studies or early-stage human clinical trials. LATITUDE is particularly proficient in the manufacture of complex liquid formulations such as nanoemulsions, liposomes, nanoparticles and other controlled-release products.
Contact us for more information and to discuss how LATITUDE can address your formulation or manufacturing needs.
Posted Date: 11/3/2022
This record has been viewed 4133 times.